Drugs and the future :: brain science, addiction and society /
This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology ap...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Amsterdam ; Boston :
Elsevier/Academic Press,
©2007.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office. |
| Beschreibung: | 1 online resource (xiii, 598 pages) : illustrations (some color) |
| Bibliographie: | Includes bibliographical references and indexes. |
| ISBN: | 9780080467740 0080467741 0123706246 9780123706249 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm86105537 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 070322s2007 ne a ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCG |d OCLCQ |d IDEBK |d OCLCQ |d OCLCO |d OCLCQ |d DKU |d OCLCQ |d AGLDB |d OCLCQ |d U3W |d OCLCF |d JBG |d VNS |d OCLCQ |d VTS |d VT2 |d OCLCQ |d OCLCO |d OCLCA |d STF |d OCLCO |d M8D |d UX1 |d HS0 |d OCLCA |d EZ9 |d INARC |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
| 015 | |a GBA657102 |2 bnb | ||
| 016 | 7 | |a 101293395 |2 DNLM | |
| 016 | 7 | |a 013499457 |2 Uk | |
| 019 | |a 437597169 |a 1055316794 |a 1081184456 |a 1190694245 |a 1193389454 |a 1228572987 | ||
| 020 | |a 9780080467740 |q (electronic bk.) | ||
| 020 | |a 0080467741 |q (electronic bk.) | ||
| 020 | |a 0123706246 | ||
| 020 | |a 9780123706249 | ||
| 035 | |a (OCoLC)86105537 |z (OCoLC)437597169 |z (OCoLC)1055316794 |z (OCoLC)1081184456 |z (OCoLC)1190694245 |z (OCoLC)1193389454 |z (OCoLC)1228572987 | ||
| 043 | |a e-uk--- | ||
| 050 | 4 | |a HV5801 |b .D78 2007eb | |
| 060 | 4 | |a 2006 N-120 | |
| 060 | 4 | |a QV 77.2 |b D7947 2007 | |
| 072 | 7 | |a SEL |x 026000 |2 bisacsh | |
| 072 | 7 | |a PSY |x 038000 |2 bisacsh | |
| 072 | 7 | |a MJN |2 bicssc | |
| 072 | 7 | |a MMZR |2 bicssc | |
| 082 | 7 | |a 362.29 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Drugs and the future : |b brain science, addiction and society / |c scientific coordinators, David Nutt [and others]. |
| 260 | |a Amsterdam ; |a Boston : |b Elsevier/Academic Press, |c ©2007. | ||
| 300 | |a 1 online resource (xiii, 598 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and indexes. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE | |
| 505 | 8 | |a 6 NEUROADAPTATIONS -- INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS | |
| 505 | 8 | |a 8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES -- EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE -- FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS | |
| 505 | 8 | |a 8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY | |
| 505 | 8 | |a 5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES | |
| 520 | |a This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office. | ||
| 650 | 0 | |a Drugs |x Social aspects. | |
| 650 | 0 | |a Drugs |x Moral and ethical aspects. | |
| 650 | 0 | |a Drug abuse. |0 http://id.loc.gov/authorities/subjects/sh85039675 | |
| 650 | 0 | |a Drug utilization |x Moral and ethical aspects. | |
| 650 | 0 | |a Drug abuse |x Government policy. | |
| 650 | 0 | |a Drug addicts |x Psychology. | |
| 650 | 0 | |a Drug addicts |x Rehabilitation. |0 http://id.loc.gov/authorities/subjects/sh85089805 | |
| 650 | 0 | |a Compulsive behavior. |0 http://id.loc.gov/authorities/subjects/sh85029465 | |
| 650 | 1 | 2 | |a Brain |x drug effects |
| 650 | 1 | 2 | |a Psychotropic Drugs |x pharmacology |
| 650 | 1 | 2 | |a Psychotropic Drugs |x therapeutic use |
| 650 | 2 | 2 | |a Behavior, Addictive |
| 650 | 2 | 2 | |a Substance-Related Disorders |
| 651 | 2 | |a United Kingdom | |
| 650 | 6 | |a Médicaments |x Aspect social. | |
| 650 | 6 | |a Médicaments |x Aspect moral. | |
| 650 | 6 | |a Toxicomanie. | |
| 650 | 6 | |a Médicaments |x Usage |x Aspect moral. | |
| 650 | 6 | |a Toxicomanie |x Politique gouvernementale. | |
| 650 | 6 | |a Toxicomanes |x Psychologie. | |
| 650 | 6 | |a Toxicomanes |x Réadaptation. | |
| 650 | 6 | |a Comportement compulsif. | |
| 650 | 7 | |a addiction. |2 aat | |
| 650 | 7 | |a SELF-HELP |x Substance Abuse & Addictions |x General. |2 bisacsh | |
| 650 | 7 | |a PSYCHOLOGY |x Psychopathology |x Addiction. |2 bisacsh | |
| 650 | 7 | |a Compulsive behavior |2 fast | |
| 650 | 7 | |a Drug abuse |2 fast | |
| 650 | 7 | |a Drug abuse |x Government policy |2 fast | |
| 650 | 7 | |a Drug addicts |x Psychology |2 fast | |
| 650 | 7 | |a Drug addicts |x Rehabilitation |2 fast | |
| 650 | 7 | |a Drugs |x Social aspects |2 fast | |
| 700 | 1 | |a Nutt, David J., |d 1951- |1 https://id.oclc.org/worldcat/entity/E39PBJtCx6M6jHbTVMw7KJBtrq |0 http://id.loc.gov/authorities/names/n94801762 | |
| 758 | |i has work: |a Drugs and the future (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGXCymTgM6X9bGYJw4h6jy |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Drugs and the future. |d Amsterdam ; Boston : Elsevier/Academic Press, ©2007 |z 0123706246 |z 9780123706249 |w (OCoLC)70229843 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=185751 |3 Volltext |
| 938 | |a EBSCOhost |b EBSC |n 185751 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 74694 | ||
| 938 | |a Internet Archive |b INAR |n drugsfuturebrain0000unse | ||
| 938 | |a YBP Library Services |b YANK |n 2537374 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm86105537 |
|---|---|
| _version_ | 1816881646090059776 |
| adam_text | |
| any_adam_object | |
| author2 | Nutt, David J., 1951- |
| author2_role | |
| author2_variant | d j n dj djn |
| author_GND | http://id.loc.gov/authorities/names/n94801762 |
| author_facet | Nutt, David J., 1951- |
| author_sort | Nutt, David J., 1951- |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | H - Social Science |
| callnumber-label | HV5801 |
| callnumber-raw | HV5801 .D78 2007eb |
| callnumber-search | HV5801 .D78 2007eb |
| callnumber-sort | HV 45801 D78 42007EB |
| callnumber-subject | HV - Social Pathology, Criminology |
| collection | ZDB-4-EBA |
| contents | Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE 6 NEUROADAPTATIONS -- INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS 8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES -- EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE -- FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS 8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY 5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES |
| ctrlnum | (OCoLC)86105537 |
| dewey-full | 362.29 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29 |
| dewey-search | 362.29 |
| dewey-sort | 3362.29 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07806cam a2200985 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm86105537 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">070322s2007 ne a ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">DKU</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCF</subfield><subfield code="d">JBG</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">UX1</subfield><subfield code="d">HS0</subfield><subfield code="d">OCLCA</subfield><subfield code="d">EZ9</subfield><subfield code="d">INARC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA657102</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101293395</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">013499457</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">437597169</subfield><subfield code="a">1055316794</subfield><subfield code="a">1081184456</subfield><subfield code="a">1190694245</subfield><subfield code="a">1193389454</subfield><subfield code="a">1228572987</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080467740</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080467741</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123706246</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123706249</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)86105537</subfield><subfield code="z">(OCoLC)437597169</subfield><subfield code="z">(OCoLC)1055316794</subfield><subfield code="z">(OCoLC)1081184456</subfield><subfield code="z">(OCoLC)1190694245</subfield><subfield code="z">(OCoLC)1193389454</subfield><subfield code="z">(OCoLC)1228572987</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">e-uk---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HV5801</subfield><subfield code="b">.D78 2007eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2006 N-120</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 77.2</subfield><subfield code="b">D7947 2007</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SEL</subfield><subfield code="x">026000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PSY</subfield><subfield code="x">038000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJN</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MMZR</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.29</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Drugs and the future :</subfield><subfield code="b">brain science, addiction and society /</subfield><subfield code="c">scientific coordinators, David Nutt [and others].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Amsterdam ;</subfield><subfield code="a">Boston :</subfield><subfield code="b">Elsevier/Academic Press,</subfield><subfield code="c">©2007.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiii, 598 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">6 NEUROADAPTATIONS -- INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES -- EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE -- FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Social aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug abuse.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039675</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug utilization</subfield><subfield code="x">Moral and ethical aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug abuse</subfield><subfield code="x">Government policy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug addicts</subfield><subfield code="x">Psychology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug addicts</subfield><subfield code="x">Rehabilitation.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85089805</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Compulsive behavior.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85029465</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Brain</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Psychotropic Drugs</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Psychotropic Drugs</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Behavior, Addictive</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Substance-Related Disorders</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United Kingdom</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Aspect social.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Aspect moral.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Toxicomanie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Usage</subfield><subfield code="x">Aspect moral.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Toxicomanie</subfield><subfield code="x">Politique gouvernementale.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Toxicomanes</subfield><subfield code="x">Psychologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Toxicomanes</subfield><subfield code="x">Réadaptation.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Comportement compulsif.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">addiction.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SELF-HELP</subfield><subfield code="x">Substance Abuse & Addictions</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSYCHOLOGY</subfield><subfield code="x">Psychopathology</subfield><subfield code="x">Addiction.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Compulsive behavior</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug abuse</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug abuse</subfield><subfield code="x">Government policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug addicts</subfield><subfield code="x">Psychology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug addicts</subfield><subfield code="x">Rehabilitation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="x">Social aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nutt, David J.,</subfield><subfield code="d">1951-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJtCx6M6jHbTVMw7KJBtrq</subfield><subfield code="0">http://id.loc.gov/authorities/names/n94801762</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Drugs and the future (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGXCymTgM6X9bGYJw4h6jy</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Drugs and the future.</subfield><subfield code="d">Amsterdam ; Boston : Elsevier/Academic Press, ©2007</subfield><subfield code="z">0123706246</subfield><subfield code="z">9780123706249</subfield><subfield code="w">(OCoLC)70229843</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=185751</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">185751</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">74694</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">drugsfuturebrain0000unse</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2537374</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| geographic | United Kingdom |
| geographic_facet | United Kingdom |
| id | ZDB-4-EBA-ocm86105537 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:16:01Z |
| institution | BVB |
| isbn | 9780080467740 0080467741 0123706246 9780123706249 |
| language | English |
| oclc_num | 86105537 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xiii, 598 pages) : illustrations (some color) |
| psigel | ZDB-4-EBA |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Elsevier/Academic Press, |
| record_format | marc |
| spelling | Drugs and the future : brain science, addiction and society / scientific coordinators, David Nutt [and others]. Amsterdam ; Boston : Elsevier/Academic Press, ©2007. 1 online resource (xiii, 598 pages) : illustrations (some color) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and indexes. Print version record. Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE 6 NEUROADAPTATIONS -- INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS 8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES -- EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE -- FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS 8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY 5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES This book presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office. Drugs Social aspects. Drugs Moral and ethical aspects. Drug abuse. http://id.loc.gov/authorities/subjects/sh85039675 Drug utilization Moral and ethical aspects. Drug abuse Government policy. Drug addicts Psychology. Drug addicts Rehabilitation. http://id.loc.gov/authorities/subjects/sh85089805 Compulsive behavior. http://id.loc.gov/authorities/subjects/sh85029465 Brain drug effects Psychotropic Drugs pharmacology Psychotropic Drugs therapeutic use Behavior, Addictive Substance-Related Disorders United Kingdom Médicaments Aspect social. Médicaments Aspect moral. Toxicomanie. Médicaments Usage Aspect moral. Toxicomanie Politique gouvernementale. Toxicomanes Psychologie. Toxicomanes Réadaptation. Comportement compulsif. addiction. aat SELF-HELP Substance Abuse & Addictions General. bisacsh PSYCHOLOGY Psychopathology Addiction. bisacsh Compulsive behavior fast Drug abuse fast Drug abuse Government policy fast Drug addicts Psychology fast Drug addicts Rehabilitation fast Drugs Social aspects fast Nutt, David J., 1951- https://id.oclc.org/worldcat/entity/E39PBJtCx6M6jHbTVMw7KJBtrq http://id.loc.gov/authorities/names/n94801762 has work: Drugs and the future (Text) https://id.oclc.org/worldcat/entity/E39PCGXCymTgM6X9bGYJw4h6jy https://id.oclc.org/worldcat/ontology/hasWork Print version: Drugs and the future. Amsterdam ; Boston : Elsevier/Academic Press, ©2007 0123706246 9780123706249 (OCoLC)70229843 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=185751 Volltext |
| spellingShingle | Drugs and the future : brain science, addiction and society / Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE 6 NEUROADAPTATIONS -- INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS 8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES -- EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE -- FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS 8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY 5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES Drugs Social aspects. Drugs Moral and ethical aspects. Drug abuse. http://id.loc.gov/authorities/subjects/sh85039675 Drug utilization Moral and ethical aspects. Drug abuse Government policy. Drug addicts Psychology. Drug addicts Rehabilitation. http://id.loc.gov/authorities/subjects/sh85089805 Compulsive behavior. http://id.loc.gov/authorities/subjects/sh85029465 Brain drug effects Psychotropic Drugs pharmacology Psychotropic Drugs therapeutic use Behavior, Addictive Substance-Related Disorders Médicaments Aspect social. Médicaments Aspect moral. Toxicomanie. Médicaments Usage Aspect moral. Toxicomanie Politique gouvernementale. Toxicomanes Psychologie. Toxicomanes Réadaptation. Comportement compulsif. addiction. aat SELF-HELP Substance Abuse & Addictions General. bisacsh PSYCHOLOGY Psychopathology Addiction. bisacsh Compulsive behavior fast Drug abuse fast Drug abuse Government policy fast Drug addicts Psychology fast Drug addicts Rehabilitation fast Drugs Social aspects fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85039675 http://id.loc.gov/authorities/subjects/sh85089805 http://id.loc.gov/authorities/subjects/sh85029465 |
| title | Drugs and the future : brain science, addiction and society / |
| title_auth | Drugs and the future : brain science, addiction and society / |
| title_exact_search | Drugs and the future : brain science, addiction and society / |
| title_full | Drugs and the future : brain science, addiction and society / scientific coordinators, David Nutt [and others]. |
| title_fullStr | Drugs and the future : brain science, addiction and society / scientific coordinators, David Nutt [and others]. |
| title_full_unstemmed | Drugs and the future : brain science, addiction and society / scientific coordinators, David Nutt [and others]. |
| title_short | Drugs and the future : |
| title_sort | drugs and the future brain science addiction and society |
| title_sub | brain science, addiction and society / |
| topic | Drugs Social aspects. Drugs Moral and ethical aspects. Drug abuse. http://id.loc.gov/authorities/subjects/sh85039675 Drug utilization Moral and ethical aspects. Drug abuse Government policy. Drug addicts Psychology. Drug addicts Rehabilitation. http://id.loc.gov/authorities/subjects/sh85089805 Compulsive behavior. http://id.loc.gov/authorities/subjects/sh85029465 Brain drug effects Psychotropic Drugs pharmacology Psychotropic Drugs therapeutic use Behavior, Addictive Substance-Related Disorders Médicaments Aspect social. Médicaments Aspect moral. Toxicomanie. Médicaments Usage Aspect moral. Toxicomanie Politique gouvernementale. Toxicomanes Psychologie. Toxicomanes Réadaptation. Comportement compulsif. addiction. aat SELF-HELP Substance Abuse & Addictions General. bisacsh PSYCHOLOGY Psychopathology Addiction. bisacsh Compulsive behavior fast Drug abuse fast Drug abuse Government policy fast Drug addicts Psychology fast Drug addicts Rehabilitation fast Drugs Social aspects fast |
| topic_facet | Drugs Social aspects. Drugs Moral and ethical aspects. Drug abuse. Drug utilization Moral and ethical aspects. Drug abuse Government policy. Drug addicts Psychology. Drug addicts Rehabilitation. Compulsive behavior. Brain drug effects Psychotropic Drugs pharmacology Psychotropic Drugs therapeutic use Behavior, Addictive Substance-Related Disorders United Kingdom Médicaments Aspect social. Médicaments Aspect moral. Toxicomanie. Médicaments Usage Aspect moral. Toxicomanie Politique gouvernementale. Toxicomanes Psychologie. Toxicomanes Réadaptation. Comportement compulsif. addiction. SELF-HELP Substance Abuse & Addictions General. PSYCHOLOGY Psychopathology Addiction. Compulsive behavior Drug abuse Drug abuse Government policy Drug addicts Psychology Drug addicts Rehabilitation Drugs Social aspects |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=185751 |
| work_keys_str_mv | AT nuttdavidj drugsandthefuturebrainscienceaddictionandsociety |